Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma

Lei Lv,Yujia Zhao,Qinqin Wei,Ye Zhao,Qiyi Yi

DOI: https://doi.org/10.1186/s12935-020-01575-3

IF: 6.429

2020-10-02

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology

What problem does this paper attempt to address?

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539
Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma (vol 11, 650173, 2021)

Kainan Zhang,Hui Liu,Mengsi Yu,Hui Zhao,Ning Yang,Xiaojuan Bi,Li Sun,Renyong Lin,Guodong Lü

DOI: https://doi.org/10.3389/fonc.2021.785394

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.650173.].
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou,He Zhang,Jun Liu,Zhenjun Zhao,Jianye Wang,Zhike Lu,Bian Hu,Jiankui Zhou,Zhicong Zhao,Mingxuan Feng,Haiyan Zhang,Bin Shen,Xingxu Huang,Beicheng Sun,Mark J. Smyth,Chuan He,Qiang Xia

DOI: https://doi.org/10.1186/s12943-020-01257-8

IF: 37.3

2020-09-04

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Qiwen Deng,Bangshun He,Tianyi Gao,Yuqin Pan,Huiling Sun,Yeqiong Xu,Rui Li,Houqun Ying,Feng Wang,Xian Liu,Jie Chen,Shukui Wang

DOI: https://doi.org/10.1371/journal.pone.0304249

IF: 3.7

2024-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0103022.].
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Haiyang Zhao,Kexin Luo,Meihan Liu,Yuanze Cai,Siman Liu,Shijuan Li,Yongsheng Zhao,Hongpan Zhang

DOI: https://doi.org/10.3389/fgene.2024.1531321

IF: 3.7

2024-12-04

Frontiers in Genetics

Abstract:This article is a correction to: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

genetics & heredity
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Chenying Lu,Shiji Fang,Qiaoyou Weng,Xiuling Lv,Miaomiao Meng,Jinyu Zhu,Liyun Zheng,Yumin Hu,Yang Gao,Xulu Wu,Jianting Mao,Bufu Tang,Zhongwei Zhao,Li Huang,Jiansong Ji

DOI: https://doi.org/10.1186/s12964-020-00674-y

IF: 7.525

2020-10-22

Cell Communication and Signaling

Abstract:An amendment to this paper has been published and can be accessed via the original article.

cell biology
Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Cheng-Cao Sun,Wei Zhu,Shu-Jun Li,Wei Hu,Jian Zhang,Yue Zhuo,Han Zhang,Juan Wang,Yu Zhang,Shao-Xin Huang,Qi-Qiang He,De-Jia Li

DOI: https://doi.org/10.1186/s13073-021-00834-w

IF: 15.266

2021-02-11

Genome Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

genetics & heredity
Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Bin Yi,Tian Wu,Nan Zhu,Yao Huang,Xiaoyu Yang,Lei Yuan,Yingjun Wu,Xiaofei Liang,Xiaoqing Jiang

DOI: https://doi.org/10.1186/s12951-021-00889-2

IF: 10.2

2021-06-12

Journal of Nanobiotechnology

Abstract:An amendment to this paper has been published and can be accessed via the original article.

biotechnology & applied microbiology,nanoscience & nanotechnology
Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Lin Lu,Deling Wang,Lili Wang,Linning E,Pingzhen Guo,Zhiming Li,Jin Xiang,Hao Yang,Hui Li,Shaohan Yin,Lawrence H. Schwartz,Chuanmiao Xie,Binsheng Zhao

DOI: https://doi.org/10.1007/s00330-020-07036-9

IF: 7.034

2020-07-22

European Radiology

Abstract:The original version of this article, published on 21 February 2020, unfortunately contained a mistake.

radiology, nuclear medicine & medical imaging
Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway

Xuehui Wang,Changle Ji,Jiashu Hu,Xiaochong Deng,Wenfang Zheng,Yunhe Yu,Kaiyao Hua,Xiqian Zhou,Lin Fang

DOI: https://doi.org/10.1186/s13046-021-02160-w

2021-11-16

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Lei Qian,Nanya Wang,Huimin Tian,Haofan Jin,Hengjun Zhao,Chao Niu,Hua He,Tingwen Ge,Wei Han,Jifan Hu,Dan Li,Fujun Han,Jianting Xu,Xiao Ding,Jingtao Chen,Wei Li,Jiuwei Cui

DOI: https://doi.org/10.1155/2022/9761463

IF: 4.4929

2022-07-18

Journal of Immunology Research

Abstract:In the article titled "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients" [1], the authors wish to correct Figure 2. Due to an oversight when preparing the manuscript, it is duplicated with Figure 3 in a previous publication by the authors [2]. These two studies were related, and the data were saved to the same location, contributing to the erroneous selection of the image for publication. The authors apologise for this error and provide the corrected Figure 2 as follows:

immunology
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Tao Shan,Shuo Chen,Tao Wu,Yi Yang,Shunle Li,Xi Chen

2022-01-01

Abstract:[This corrects the article on p. 1764 in vol. 12, PMID: 31933995.].
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum to “clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma”

Shuai Sun,Bowen Li,Yufan Wang,Xiang Li,Panpan Wang,Feng Wang,Wei Zhang,Hongyu Yang

DOI: https://doi.org/10.1155/2019/2434063

2019-01-01

Disease Markers

Abstract:[This corrects the article DOI: 10.1155/2018/6514795.].
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Yong-Zheng Zhang,Amir Zeb,Lu-Feng Cheng

DOI: https://doi.org/10.3389/fimmu.2023.1168774

IF: 7.3

2023-02-28

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1032819.].

immunology
Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

Chao Xia,Wei Huang,Yun-Liang Chen,Hai-Bin Fu,Ming Tang,Tao-Lan Zhang,Jing Li,Guo-Hua Lv,Yi-Guo Yan,Zhi-Hua Ouyang,Nvzhao Yao,Cheng Wang,Ming-Xiang Zou

DOI: https://doi.org/10.3389/fimmu.2023.1194064

IF: 7.3

2023-04-14

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.797407.].

immunology
Correction to: Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma

Guocai Tian,You Fu,Dahe Zhang,Jiang Li,Zhiyuan Zhang,Xi Yang

DOI: https://doi.org/10.1186/s12935-021-01904-0

IF: 6.429

2021-05-04

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Weipu Mao,Keyi Wang,Bin Xu,Hui Zhang,Si Sun,Qiang Hu,Lei Zhang,Chunhui Liu,Shuqiu Chen,Jianping Wu,Ming Chen,Wei Li,Bo Peng

DOI: https://doi.org/10.1186/s12943-021-01459-8

IF: 37.3

2021-12-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology

Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma (vol 11, 650173, 2021)

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum to “clinical Significance of the Decreased Expression of Hsa_circ_001242 in Oral Squamous Cell Carcinoma”

Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

Correction to: Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma